Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial
暂无分享,去创建一个
S. Achenbach | A. Schmermund | R. Erbel | W. Moshage | E. Steinhagen-Thiessen | M. Henein | T. Budde | F. Knollmann | W. Siffert | R. Leischik | V. Sinitsyn | G. Kerkhoff | A. Lahiri | G. Friedrich | A. Förster | Y. Buziashvili | A. Vogt | M. Schartl | V. Kukharchuk | B. Wiedeking
[1] T. Callister,et al. Aggressive Versus Moderate Lipid-Lowering Therapy in Hypercholesterolemic Postmenopausal Women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES) , 2005, Circulation.
[2] Y. Arad,et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. , 2005, Journal of the American College of Cardiology.
[3] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[4] E. Mohler,et al. Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and Osteoblasts: Implications for End-Stage Valvular Heart Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[5] A. Schmermund,et al. Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries , 2004, Circulation.
[6] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[7] T. Callister,et al. Progression of Coronary Artery Calcium and Risk of First Myocardial Infarction in Patients Receiving Cholesterol-Lowering Therapy , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[8] Richard M. Moe,et al. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. , 2004, Journal of the American College of Cardiology.
[9] Paul Schoenhagen,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.
[10] Raimund Erbel,et al. Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound , 2003, Circulation.
[11] Paul Schoenhagen,et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[12] E. Boerwinkle,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.
[13] M. Budoff,et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. , 2003, The American journal of cardiology.
[14] H. Hecht,et al. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography. , 2003, The American journal of cardiology.
[15] G. Mancia,et al. European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[16] Allen J. Taylor,et al. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness , 2002, Circulation.
[17] S. Achenbach,et al. Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery Calcification: A Prospective Evaluation , 2002, Circulation.
[18] Jonathan G Goldin,et al. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. , 2002, Radiology.
[19] H. C. Stary,et al. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. , 2001, The American journal of cardiology.
[20] D. Grönemeyer,et al. Natural History and Topographic Pattern of Progression of Coronary Calcification in Symptomatic Patients: An Electron-Beam CT Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[21] M. Trip,et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.
[22] Renu Virmani,et al. Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.
[23] S. Achenbach,et al. Variability of repeated coronary artery calcium measurements by electron beam tomography. , 2001, The American journal of cardiology.
[24] B. Hoogwerf,et al. Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial , 2000 .
[25] M. Budoff,et al. Rates of progression of coronary calcium by electron beam tomography. , 2000, The American journal of cardiology.
[26] L. Bielak,et al. Progression of coronary artery calcification: a pilot study. , 1999, Mayo Clinic proceedings.
[27] T. Callister,et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. , 1998, The New England journal of medicine.
[28] T. Callister,et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.
[29] J. Rumberger,et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. , 1995, Circulation.
[30] T. Craven,et al. Prognostic Significance of Progression of Coronary Atherosclerosis , 1993, Circulation.
[31] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[32] Eric J Topol,et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.
[33] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. , 2004, Journal of the American College of Cardiology.
[34] Michael Miller. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[35] G. Mancia,et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003, European heart journal.
[36] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[37] L. Bielak,et al. Coronary artery calcification measured at electron-beam CT: agreement in dual scan runs and change over time. , 2001, Radiology.
[38] Ken W. Woodhouse,et al. The Clinical Perspective , 1994 .